Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Daan De Maeseneer

Awards & Distinctions

36 Results

2025

Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer : a phase 2 trial : results of secondary endpoints

Flor VerghoteElke RammantPiet DirixCharles Van PraetCharlien BerghenSara JuniusNick LiefhoogheLeen NoéPiet OstKarel Decaestecker et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

2024

Can PET-CT improve the staging and outcome of patients with muscle-invasive bladder cancer?

Valerie FonteyneFlor VerghoteCamille BerquinDaan De MaeseneerGeert VilleirsKathia De Man

A2 Journal Article in AME CLINICAL TRIALS REVIEW

Rare type of Bellini duct carcinoma in a patient with Cacchi–Ricci disease : a case report and mini-review

Antonio FrancoThomas TaillyCamille BerquinDaan De MaeseneerAlexander DecruyenaereSofie VerbekePieter De VisschereKathia De ManLaurens HermieBen Vanneste et al.

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Retrospective analysis of multiparametric MRI in predicting complete pathologic response of neo-adjuvant chemotherapy in bladder cancer

Daan De MaeseneerPieter De VisschereMats Van den broeckeFelix DelbareGeert VilleirsSofie VerbekeValerie FonteyneCharles Van PraetKarel DecaesteckerAlexander Decruyenaere et al.

A1 Journal Article in BMC MEDICAL IMAGING

2023

Checkpoint inhibitors in combination with stereotactic body radiotherapy in patients with advanced solid tumors : the CHEERS phase 2 randomized clinical trial

Mathieu SpaasNora SundahlVibeke KruseSylvie RotteyDaan De MaeseneerFréderic DuprezYolande LievensVeerle SurmontLieve BrochezDries Reynders et al.

A1 Journal Article in JAMA ONCOLOGY

Indicaties voor radiotherapie bij blaaskanker met spierinvasie

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

A4 Journal Article in ONCO (NEDERLANDSE ED.)

Radiotherapy use in muscle-invasive bladder cancer : review of the guidelines and impact of increased awareness in patient referral at a tertiary center in Belgium

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

A1 Journal Article in CANCER MANAGEMENT AND RESEARCH

Role of radiotherapy as primary treatment for muscle-invasive bladder cancer : review of the guidelines and single-centre pattern of care analysis

Flor VerghoteCharles Van PraetDaan De MaeseneerCamille BerquinBen VannestePieter De VisschereSofie VerbekeValerie Fonteyne

Success rate of in-bore MRI-guided prostate biopsy based on radical prostatectomy and/or follow-up

Laura SchelfautBart De troyerSifrid HendrickxCharles Van PraetFriedl VanhaverbekeSofie VerbekeGeert VilleirsHendrik WynantPieter De VisschereNicolaas Lumen et al.

2022

Adjuvant radiotherapy after radical cystectomy for patients with high-risk muscle-invasive bladder cancer : results of a multicentric phase II trial

Valerie FonteyneP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheL. NoéG. De MeerleerPiet Ost et al.

A1 Journal Article in EUROPEAN UROLOGY FOCUS

Highlights in genitourinary cancer

Tijl VermassenAlexander DecruyenaereSylvie RotteyDaan De Maeseneer

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Highlights in genitourinary cancers

Alexander DecruyenaereSylvie RotteyDaan De MaeseneerTijl Vermassen

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Practical guidance for molecular testing in metastatic prostate cancer : a Belgian perspective

Sofie VerbekeS VerschuereM-D Martin-MartinezBart LelieLouis LibbrechtM BaldewijnsS RoriveG BeniugaJ EbenM-A Van Caillie et al.

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

2021

Adjuvant radiotherapy after radical cystectomy for patients with muscle invasive bladder cancer : results of a phase 2 trial

Flor VerghoteP. DirixCharles Van PraetC. BerghenM. AlbersenS. JuniusN. LiefhoogheM. BrosensG. De MeerleerPiet Ost et al.

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS) : study protocol for a phase 2, open-label, randomized controlled trial

Mathieu SpaasNora SundahlEva HulstaertVibeke KruseSylvie RotteyDaan De MaeseneerVeerle SurmontAnnabel MeiresonLieve BrochezDries Reynders et al.

A1 Journal Article in BMC CANCER

Evaluating the impact of 18F-FDG-PET-CT on risk stratification and treatment adaptation for patients with muscle-invasive bladder cancer (EFFORT-MIBC) : a phase II prospective trial

Flor VerghoteLindsay PoppeSofie VerbekePiet DirixMaarten AlbersenGert De MeerleerCharlien BerghenPiet OstGeert VilleirsPieter De Visschere et al.

A1 Journal Article in BMC CANCER

Highlights in genitourinary cancers

Tijl VermassenSylvie RotteyDaan De Maeseneer

Immuno-radiotherapy in solid tumors : preliminary results of the randomized phase 2 CHEERS trial

Mathieu SpaasNora SundahlSylvie RotteyVIBEKE KRUSEDaan De MaeseneerFréderic DuprezPiet DirixVeerle SurmontYolande LievensRobin Van den Begin et al.

Retrospective analysis of mpMRI to predict complete pathologic response after neo-adjuvant chemotherapy for muscle invasive bladder cancer

Daan De MaeseneerPieter De VisschereMats Van den broeckeGeert VilleirsKarel DecaesteckerSylvie Rottey

2020

Targeting FGFR in bladder cancer : ready for clinical practice?

Stijn De KeukeleireDaan De MaeseneerCeline JacobsSylvie Rottey

A1 Journal Article in ACTA CLINICA BELGICA

2019

Introducing a castrate resistant prostate cancer (CRPC) model care pathway in Belgian hospitals : towards national standardization?

Tijl VermassenThierry RoumeguereYannick NeybuchLucien HoekxIrena FeleBrieuc SautoisWouter EveraertsDaan De MaeseneerFrederic LecouvetNicolaas Lumen et al.

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Randomized phase 1 trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma: Clinical and translational results

Piet OstNora SundahlG VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls Goetghebeur et al.

Randomized phase 1 trial of pembrolizumab with sequential versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma

Nora SundahlGillian VandekerkhoveKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

A1 Journal Article in EUROPEAN UROLOGY

Randomized phase I trial of pembrolizumab with neo-adjuvant versus concomitant stereotactic body radiotherapy in metastatic urothelial carcinoma : clinical and translational results

Gillian VandekerkhoveNora SundahlKarel DecaesteckerAnnabel MeiresonPieter De VisschereValerie FonteyneDaan De MaeseneerDries ReyndersEls GoetghebeurJo Van Dorpe et al.

2018

Evaluating the current place of radiotherapy as treatment option for patients with muscle invasive bladder cancer in Belgium

Valerie FonteyneElke RammantPiet OstYolande LievensBart De TroyerSylvie RotteyGert De MeerleerDaan De MaeseneerDirk De RidderKarel Decaestecker

A1 Journal Article in CLINICAL GENITOURINARY CANCER

Pembrolizumab for the treatment of bladder cancer

Nora SundahlSylvie RotteyDaan De MaeseneerPiet Ost

A1 Journal Article in EXPERT REVIEW OF ANTICANCER THERAPY

2017

A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma : evaluation of safety and clinical and immunologic response

Nora SundahlKatrien De WolfSylvie RotteyKarel DecaesteckerDaan De MaeseneerAnnabel MeiresonEls GoetghebeurValerie FonteyneSofie VerbekePieter De Visschere et al.

A1 Journal Article in JOURNAL OF TRANSLATIONAL MEDICINE

Checkpoint inhibition : new treatment options in urologic cancer

Daan De MaeseneerBrant DelafontaineSylvie Rottey

A1 Journal Article in ACTA CLINICA BELGICA

Combined high dose radiation and pazopanib in metastatic renal cell carcinoma : a phase I dose escalation trial

Katrien De WolfSylvie RotteyKarim VermaelenKarel DecaesteckerNora SundahlLizzy De LobelEls GoetghebeurGert De MeerleerNicolaas LumenValerie Fonteyne et al.

A1 Journal Article in RADIATION ONCOLOGY

Parathyroid adenoma mimicking a malignant lymph node on F-18-choline PET-CT

Bliede Van den BroeckDaan De MaeseneerRuth De GersemKathia De Man

Editorial material

Prostaatkanker en de rol van de huisarts

Marco BlankerKristel van AsseltSylvie RotteyDaan De MaeseneerFilip Poelaert

Bookchapter in Oncologie

2013

Attacking the androgen receptor pathway in prostate cancer

Charles Van PraetDaan De MaeseneerNicolaas LumenSylvie Rottey

A2 Journal Article in BELGIAN JOURNAL OF MEDICAL ONCOLOGY

Multicenter cross-sectional study comparing quality of life, body image after breast cancer surgery

Daan De MaeseneerMICHIEL STRIJBOSPhillip BlondeelRudy Van den BroeckeHerman DepypereGeert BraemsHannelore DenysSimon Van BelleVeronique Cocquyt

Proctological problems in relation to chemotherapy

Tom LagaertBRUNO VANDUYFHUYSBEATRIJS STRUBBEINGRID BRUGGEMANKOEN GORLEERPieter HindryckxDaan De MaeseneerIne MoorsStéphanie LaurentKaren Geboes et al.

2010

18-Fluorodeoxyglucose positron emission tomography as a tool for response prediction in solid tumours

Daan De MaeseneerBieke LambertVeerle SurmontKaren GeboesSylvie Rottey

A1 Journal Article in ACTA CLINICA BELGICA

2007

Cell motility and breast cancer metastasis.

Marc BrackeDaan De MaeseneerVeerle Van MarckLara DeryckeBarbara VanhoeckeOlivier De WeverHerman Depypere

Bookchapter in Metastasis of Breast Cancer.